NEW YORK (GenomeWeb News) – CellAura will provide its fluorescent reagents to Cisbio Bioassays for use with its non-radioactive assays for cellular studies, CellAura said today.

Under the agreement, CellAura will develop a number of reagents for Cisbio's Tag-lite platform, which is used for studies of cell surface receptor dimerization and ligand binding.

CellAura, a spin-out from the University of Nottingham, will retain the rights for the reagents developed for use in its own range of assays for certain markets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.